Management of Ovarian Endometrioma in Asymptomatic Reproductive Age Women

Purpose of Review In asymptomatic women of reproductive age, the presence of an ovarian endometrioma raises a significant management dilemma. Recent Findings Surgical management may afford more definitive treatment as well as an opportunity to treat concurrent extra-ovarian endometriotic disease. However, the associated impact on ovarian reserve with ovarian surgery may be an example of the cure being worse than the disease. Several conservative treatments have been studied, all with varying clinical benefits. Expectant management, while a conservative option, may complicate access to growing ovarian follicles and raise risk of surgical site infection during assisted reproductive treatment. Furthermore, a growing body of data suggests that prolonged exposure to the inflammatory endometrioma contributes to ovarian follicular burnout and cortical scarring. Summary For patients with a diagnosis of endometrioma who are actively trying to conceive, careful patient counseling and shared decision making represent the best way to decide on a management strategy in order to maximize patient-centered outcomes and reproductive potential. Similar content being viewed by others

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382(13):1244–56. Kitajima M, Dolmans M-M, Donnez O, Masuzaki H, Soares M, Donnez J. Enhanced follicular recruitment and atresia in cortex derived from ovaries with endometriomas. Fertil Steril. 2014;101(4):1031–7. Exacoustos C, De Felice G, Pizzo A, Morosetti G, Lazzeri L, Centini G, et al. Isolated ovarian endometrioma: a history between myth and reality. J Minim Invasive Gynecol. 2018;25(5):884–91. Redwine DB. Ovarian endometriosis: a marker for more extensive pelvic and intestinal disease. Fertil Steril. 1999;72(2):310–5. Chapron C, Pietin-Vialle C, Borghese B, Davy C, Foulot H, Chopin N. Associated ovarian endometrioma is a marker for greater severity of deeply infiltrating endometriosis. Fertil Steril. 2009;92(2):453–7. Somigliana E, Infantino M, Candiani M, Vignali M, Chiodini A, Busacca M, et al. Association rate between deep peritoneal endometriosis and other forms of the disease: pathogenetic implications. Hum Reprod Oxf Engl. 2004;19(1):168–71. • Lee N, Min S, Won S, Cho YJ, Kim M, Kim MK, et al. The recurrence rate of ovarian endometrioma in women aged 40–49years and impact of hormonal treatment after conservative surgery. Sci Rep. 2020;10(1):16461. This study found that ovarian endometrioma recurred in 34 (8.3%) of women and the median time to recurrence was 22.4 ± 18.2 months. The cumulative recurrences rate at 12, 24, 36, and 60 months were 3.7%, 6.7%, 11.1%, and 16.7%. Gordts S, Puttemans P, Gordts S, Brosens I. Ovarian endometrioma in the adolescent: a plea for early-stage diagnosis and full surgical treatment. Gynecol Surg. 2015;12(1):21–30. ASRM. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997;67(5):817–21. Bulun SE. Endometriosis. N Engl J Med. 2009;360(3):268–79. Pateman K, Moro F, Mavrelos D, Foo X, Hoo W-L, Jurkovic D. Natural history of ovarian endometrioma in pregnancy. BMC Womens Health. 2014;14:128. Fernando S, Breheny S, Jaques AM, Halliday JL, Baker G, Healy D. Preterm birth, ovarian endometriomata, and assisted reproduction technologies. Fertil Steril. 2009;91(2):325–30. Seyhan A, Urman B, Turkgeldi E, Ata B. Do endometriomas grow during ovarian stimulation for assisted reproduction? A three-dimensional volume analysis before and after ovarian stimulation. Reprod Biomed Online. 2018;36(2):239–44. Collins BG, Ankola A, Gola S, McGillen KL. Transvaginal US of endometriosis looking beyond the endometrioma with a dedicated protocol. Radiogr Rev Publ Radiol Soc N Am Inc. 2019;39(5):1549–68. Cranney R, Condous G, Reid S. An update on the diagnosis, surgical management, and fertility outcomes for women with endometrioma. Acta Obstet Gynecol Scand. 2017;96(6):633–43. Nisenblat V, Bossuyt PMM, Farquhar C, Johnson N, Hull ML. Imaging modalities for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2016;2:CD009591. Vercellini P, Bocciolone L, Vendola N, Colombo A, Rognoni MT, Fedele L. Peritoneal endometriosis. Morphologic appearance in women with chronic pelvic pain. J Reprod Med. 1991;36(7):533–6. Nnoaham KE, Hummelshoj L, Kennedy SH, Jenkinson C, Zondervan KT, World Endometriosis Research Foundation Women’s Health Symptom Survey Consortium. Developing symptom-based predictive models of endometriosis as a clinical screening tool: results from a multicenter study. Fertil Steril. 2012;98(3):692–701. Hudelist G, Ballard K, English J, Wright J, Banerjee S, Mastoroudes H, et al. Transvaginal sonography vs clinical examination in the preoperative diagnosis of deep infiltrating endometriosis. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 2011;37(4):480–7. Lee D, Kim SK, Lee JR, Jee BC. Management of endometriosis-related infertility: considerations and treatment options. Clin Exp Reprod Med. 2020;47(1):1–11. Daraï E, Detchev R, Hugol D, Quang NT. Serum and cyst fluid levels of interleukin (IL) -6 IL-8 and tumour necrosis factor-alpha in women with endometriomas and benign and malignant cystic ovarian tumours. Hum Reprod Oxf Engl. 2003;18(8):1681–5. Tseng JF, Ryan IP, Milam TD, Murai JT, Schriock ED, Landers DV, et al. Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis. J Clin Endocrinol Metab. 1996;81(3):1118–22. Jayaprakasan K, Becker C, Mittal M. The effect of surgery for endometriomas on fertility: Scientific Impact Paper no 55. BJOG Int J Obstet Gynaecol. 2018;125(6):e19-28. Matsuzaki S, Schubert B. Oxidative stress status in normal ovarian cortex surrounding ovarian endometriosis. Fertil Steril. 2010;93(7):2431–2. Miravet-Valenciano J, Ruiz-Alonso M, Gómez E, Garcia-Velasco JA. Endometrial receptivity in eutopic endometrium in patients with endometriosis: it is not affected and let me show you why. Fertil Steril. 2017;108(1):28–31. Kasapoglu I, Ata B, Uyaniklar O, Seyhan A, Orhan A, Yildiz Oguz S, et al. Endometrioma-related reduction in ovarian reserve (ERROR): a prospective longitudinal study. Fertil Steril. 2018;110(1):122–7. •• Ferrero H, Corachán A, Aguilar A, Quiñonero A, Carbajo-García MC, Alamá P, et al. Single-cell RNA sequencing of oocytes from ovarian endometriosis patients reveals a differential transcriptomic profile associated with lower quality. Hum Reprod Oxf Engl. 2019;34(7):1302–12. This study found that oocytes from endometriosis patients, independently of whether they came from the affected ovary, exhibited a differential transcriptomic profile compared to oocytes from healthy egg donors. Kobayashi H, Sumimoto K, Kitanaka T, Yamada Y, Sado T, Sakata M, et al. Ovarian endometrioma—Risks factors of ovarian cancer development. Eur J Obstet Gynecol Reprod Biol. 2008;138(2):187–93. Nargund G, Parsons J. Infected endometriotic cysts secondary to oocyte aspiration for in-vitro fertilization. Hum Reprod Oxf Engl. 1995;10(6):1555. Padilla SL. Case Report: Ovarian abscess following puncture of an endometrioma during ultrasound-guided oocyte retrieval. Hum Reprod. 1993;8(8):1282–3. Evangelinakis N, Grammatikakis I, Salamalekis G, Tziortzioti V, Samaras C, Chrelias C, et al. Prevalence of acute hemoperitoneum in patients with endometriotic ovarian cysts: a 7-year retrospective study. Clin Exp Obstet Gynecol. 2009;36(4):254–5. Busacca M, Riparini J, Somigliana E, Oggioni G, Izzo S, Vignali M, et al. Postsurgical ovarian failure after laparoscopic excision of bilateral endometriomas. Am J Obstet Gynecol. 2006;195(2):421–5. Vignali M, Belloni GM, Pietropaolo G, Prun ABD, Barbera V, Angioni S, et al. Effect of Dienogest therapy on the size of the endometrioma. Gynecol Endocrinol. 2020;36(8):723–7. Harada T, Momoeda M, Taketani Y, Hoshiai H, Terakawa N. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled double-blind randomized trial. Fertil Steril. 2008;90(5):1583–8. Kavoussi SK, Odenwald KC, As-Sanie S, Lebovic DI. Incidence of ovarian endometrioma among women with peritoneal endometriosis with and without a history of hormonal contraceptive use. Eur J Obstet Gynecol Reprod Biol. 2017;215:220–3. Donnez J, Nisolle M, Gillerot S, Anaf V, Clerckx-Braun F, Casanas-Roux F. Ovarian endometrial cysts: the role of gonadotropin-releasing hormone agonist and/or drainage. Fertil Steril. 1994;62(1):63–6. Cohen A, Almog B, Tulandi T. Sclerotherapy in the management of ovarian endometrioma: systematic review and meta-analysis. Fertil Steril. 2017;108(1):117–24. Raffi F, Metwally M, Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012;97(9):3146–54. Zhang N-N, Sun T-S, Yang Q. An effective “water injection”-assisted method for excision of ovarian endometrioma by laparoscopy. Fertil Steril. 2019;112(3):608–9. Mircea O, Puscasiu L, Resch B, Lucas J, Collinet P, von Theobald P, et al. Fertility outcomes after ablation using plasma energy versus cystectomy in infertile women with ovarian endometrioma: a multicentric comparative study. J Minim Invasive Gynecol. 2016;23(7):1138–45. Donnez J, Nisolle M, Gillet N, Smets M, Bassil S, Casanas-Roux F. Large ovarian endometriomas. Hum Reprod Oxf Engl. 1996;11(3):641–6. Pados G, Tsolakidis D, Assimakopoulos E, Athanatos D, Tarlatzis B. Sonographic changes after laparoscopic cystectomy compared with three-stage management in patients with ovarian endometriomas: a prospective randomized study. Hum Reprod. 2010;25(3):672–7. Tsolakidis D, Pados G, Vavilis D, Athanatos D, Tsalikis T, Giannakou A, et al. The impact on ovarian reserve after laparoscopic ovarian cystectomy versus three-stage management in patients with endometriomas: a prospective randomized study. Fertil Steril. 2010;94(1):71–7. Vercellini P, De Matteis S, Somigliana E, Buggio L, Frattaruolo MP, Fedele L. Long-term adjuvant therapy for the prevention of postoperative endometrioma recurrence: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2013;92(1):8–16. Fedele L, Bianchi S, Zanconato G, Berlanda N, Raffaelli R, Fontana E. Laparoscopic excision of recurrent endometriomas: long-term outcome and comparison with primary surgery. Fertil Steril. 2006;85(3):694–9. Muneyyirci-Delale O, Anopa J, Charles C, Mathur D, Parris R, Cutler JB, et al. Medical management of recurrent endometrioma with long-term norethindrone acetate. Int J Womens Health. 2012;4:149–54. Lall Seal S, Kamilya G, Mukherji J, De A, Ghosh D, Majhi AK. Aromatase inhibitors in recurrent ovarian endometriomas: report of five cases with literature review. Fertil Steril. 2011;95(1):291.e15-18. Velasco I, Rueda J, Acién P. Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis. Mol Hum Reprod. 2006;12(6):377–81. Loverro G, Carriero C, Rossi AC, Putignano G, Nicolardi V, Selvaggi L. A randomized study comparing triptorelin or expectant management following conservative laparoscopic surgery for symptomatic stage III–IV endometriosis. Eur J Obstet Gynecol Reprod Biol. 2008;136(2):194–8. Jee BC, Lee JY, Suh CS, Kim SH, Choi YM, Moon SY. Impact of GnRH agonist treatment on recurrence of ovarian endometriomas after conservative laparoscopic surgery. Fertil Steril. 2009;91(1):40–5. Muzii L, Marana R, Caruana P, Catalano GF, Margutti F, Panici PB. Postoperative administration of monophasic combined oral contraceptives after laparoscopic treatment of ovarian endometriomas: a prospective randomized trial. Am J Obstet Gynecol. 2000;183(3):588–92. Vercellini P, Somigliana E, Daguati R, Vigano P, Meroni F, Crosignani PG. Postoperative oral contraceptive exposure and risk of endometrioma recurrence. Am J Obstet Gynecol. 2008;198(5):504.e1-5. Seracchioli R, Mabrouk M, Frascà C, Manuzzi L, Montanari G, Keramyda A, et al. Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial. Fertil Steril. 2010;93(1):52–6. Sesti F, Capozzolo T, Pietropolli A, Marziali M, Bollea MR, Piccione E. Recurrence rate of endometrioma after laparoscopic cystectomy: a comparative randomized trial between post-operative hormonal suppression treatment or dietary therapy vs. placebo. Eur J Obstet Gynecol Reprod Biol. 2009;147(1):72–7. Koga K, Osuga Y, Takemura Y, Takamura M, Taketani Y. Recurrence of endometrioma after laparoscopic excision and its prevention by medical management. Front Biosci Elite Ed. 2013;5:676–83. Author information Authors and Affiliations Contributions The authors contributed to the writing, editing, and submission of the manuscript. Corresponding author Ethics declarations Consent to Participate Not applicable. Consent for Publication Not applicable. Conflict of Interest The authors declare no competing interests. Human and Animal Rights and Informed Consent This article does not contain any studies with human or animal subjects performed by any of the authors. Additional information Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. This article is part of the Topical Collection on Reproductive Endocrinology and Infertility (REI) Rights and permissions About this article Cite this article Bortoletto, P., Pollie, M. Management of Ovarian Endometrioma in Asymptomatic Reproductive Age Women. Curr Obstet Gynecol Rep 10, 53–60 (2021). https://doi.org/10.1007/s13669-021-00311-6 Accepted: Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s13669-021-00311-6